Ticker Scorecard - ARCT Basics Company: Arcturus Therapeutics Holdings Inc. IPO Date: May 22, 2013 Sector: Healthcare Industry: Biotech Market Cap: $447.75M Activated in VL: True Average Daily Range Avg Daily Range: $1.04 | 3.86% Avg Daily Range (30 D): $0.65 | 3.72% Avg Daily Range (90 D): $0.60 | 3.18% Institutional Daily Volume Avg Daily Volume: .38M Avg Daily Volume (30 D): .3M Avg Daily Volume (90 D): .31M Trade Size Avg Trade Size (Sh.): 65 Avg Trade Size (Sh.) (30 D): 47 Avg Trade Size (Sh.) (90 D): 48 Institutional Trades Total Inst.Trades: 1,891 Avg Inst. Trade: $2.14M Avg Inst. Trade (30 D): $1.13M Avg Inst. Trade (90 D): $1.18M Avg Inst. Trade Volume: .07M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.47M Avg Closing Trade (30 D): $1.1M Avg Closing Trade (90 D): $1.18M Avg Closing Volume: 78.85K     News Dec 8, 2024 @ 1:00 PM mRNA Therapeutics Market Size to Hit USD 48.65 Bil... Source: Sns Insider Oct 14, 2024 @ 3:48 PM mRNA Cancer Vaccines and Therapeutics Research Rep... Source: Researchandmarkets.Com Sep 30, 2024 @ 3:12 PM Arcturus Therapeutics/CSL Partnered COVID-19 Vacci... Source: Vandana Singh Sep 13, 2024 @ 12:15 PM Japan's Ministry of Health, Labor and Welfare Appr... Source: Prnewswire Sep 3, 2024 @ 8:44 PM Does Arcturus Therapeutics Have the Potential to R... Source: Zacks Financials   TTM Q3 2024 Q2 2024 Basic EPS $-2.33 $-.26 $-.64 Diluted EPS $-2.34 $-.26 $-.64 Revenue $ 160.4M $ 41.67M $ 49.86M Gross Profit $ $ $ Net Income / Loss $ -62.64M $ -6.9M $ -17.22M Operating Income / Loss $ -80.55M $ -10.74M $ -21.13M Cost of Revenue $ $ $ Net Cash Flow $ -74.99M $ -23.15M $ -28.07M PE Ratio     Splits Nov 16, 2017:   7:1